Medi Assist vs MedPlus vs Nephroplus: Which Stock Should You Track
- October 5, 2026
- Posted by: Chaitanya Auti
- Category: Market
Medi Assist Healthcare Services PE 23.69, mkt cap Rs 2,233 crore. MedPlus Health Services PE 37.35, mkt cap Rs 7,861 crore. Nephroplus PE 76.48, mkt cap Rs 6,507 crore.
Quick Answer
Medi Assist Healthcare Services vs MedPlus Health Services vs Nephroplus is a side-by-side comparison of three companies from the Healthcare Services space. On this comparison, Medi Assist Healthcare Services carries a market capitalisation of about Rs 2,233 crore against Rs 7,861 crore for MedPlus Health Services and Rs 6,507 crore for Nephroplus, with return on equity of 11.47%, 11.12% and 6.88% respectively. Each company’s numbers are presented here without a declared better pick, since the right stock depends on an investor’s own criteria.
Medi Assist Healthcare Services vs MedPlus Health Services vs Nephroplus starts with the core numbers most investors compare within the Healthcare Services segment: market capitalisation, valuation multiples, profitability and dividend yield. Figures below are sourced as of September 2026 and will shift with daily price moves.
All three names sit in the Healthcare Services bucket, which makes them a natural set to place side by side rather than a random trio of unrelated businesses.
Click Here – Get Free Investment Predictions
Medi Assist Healthcare Services, MedPlus Health Services and Nephroplus: Company Overview
Medi Assist Healthcare Services is a listed Indian company in the Healthcare Services space, tracked here on book value, return ratios and valuation alongside its peers in this comparison.
MedPlus Health Services is a listed Indian company in the Healthcare Services space, tracked here on book value, return ratios and valuation alongside its peers in this comparison.
Nephroplus is a listed Indian company in the Healthcare Services space, tracked here on book value, return ratios and valuation alongside its peers in this comparison.
Medi Assist Healthcare Services vs MedPlus Health Services vs Nephroplus: Valuation and Profitability Snapshot
| Metric | Medi Assist Healthcare Services | MedPlus Health Services | Nephroplus |
|---|---|---|---|
| Market Cap (approx.) | Rs 2,233 crore | Rs 7,861 crore | Rs 6,507 crore |
| PE Ratio (TTM) | 23.69 | 37.35 | 76.48 |
| PB Ratio | 2.79 | 3.98 | 5.83 |
| Return on Equity (ROE) | 11.47% | 11.12% | 6.88% |
| EPS (TTM, Rs) | 12.62 | 17.52 | 8.46 |
| Dividend Yield | 0.67% | 0.00% | 0.00% |
| Debt to Equity | 0.06 | 0.72 | 0.07 |
| Book Value per Share (Rs) | 107.23 | 164.43 | 111.03 |
Check the Univest Screener for Live Data
On valuation, Medi Assist Healthcare Services trades at a PE of 23.69 and a PB of 2.79, MedPlus Health Services at a PE of 37.35 and a PB of 3.98, while Nephroplus trades at a PE of 76.48 and a PB of 5.83. On return on equity, the three post 11.47%, 11.12% and 6.88% respectively, and on dividend yield they stand at 0.67%, 0.00% and 0.00%.
Medi Assist Healthcare Services vs MedPlus Health Services vs Nephroplus: Latest Quarterly Results
| Company | Latest Quarter Revenue | Latest Quarter Net Profit | YoY Change (Revenue) | QoQ Change (Revenue) |
|---|---|---|---|---|
| Medi Assist Healthcare Services | Rs 247.02 crore | Rs 27.60 crore | +24.9% | +0.9% |
| MedPlus Health Services | Rs 1,899.43 crore | Rs 33.17 crore | +21.9% | +0.8% |
| Nephroplus | Rs 289.21 crore | Rs 31.97 crore | +23.4% | +4.3% |
Quarterly figures above are the most recent reported quarter for each company (Q1 FY27, quarter ended June 2026), compared with the year-ago and preceding quarter.
Download the Univest iOS App or Univest Android App to track Medi Assist Healthcare Services, MedPlus Health Services and Nephroplus live prices.
What Should Investors Look at Beyond These Numbers?
Beyond the metrics above, investors comparing these three healthcare services names should track quarter-on-quarter revenue and margin trends, management commentary on demand and cost drivers, and any sector-specific regulatory developments, since a single-quarter snapshot can shift quickly.
Conclusion
Medi Assist Healthcare Services vs MedPlus Health Services vs Nephroplus highlights how differently three companies in the same healthcare services segment can score across valuation, profitability and dividend metrics, even when operating in a similar space. This comparison does not declare a winner; investors should weigh these figures against their own research and risk appetite. Please read the disclaimer below before making any investment decision.
Disclaimer: Data and figures in this article are sourced from publicly available information as of September 2026 and may not reflect real-time prices. Please verify all data independently before making any investment decision. This comparison does not recommend or endorse any single stock over another; investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
FAQs on Medi Assist Healthcare Services vs MedPlus Health Services vs Nephroplus
What is the market cap difference between Medi Assist Healthcare Services, MedPlus Health Services and Nephroplus?
Ans. As of September 2026, Medi Assist Healthcare Services has a market cap of approximately Rs 2,233 crore, MedPlus Health Services is at approximately Rs 7,861 crore, and Nephroplus is at approximately Rs 6,507 crore.
Which of the three has the highest PE ratio?
Ans. Among Medi Assist Healthcare Services, MedPlus Health Services and Nephroplus, the PE ratios stand at 23.69, 37.35 and 76.48 respectively as of September 2026.
Which of the three has the highest ROE?
Ans. Medi Assist Healthcare Services, MedPlus Health Services and Nephroplus post ROE of 11.47%, 11.12% and 6.88% respectively as of September 2026.
Which of these three stocks pays the highest dividend yield?
Ans. Medi Assist Healthcare Services, MedPlus Health Services and Nephroplus carry dividend yields of 0.67%, 0.00% and 0.00% respectively.
What is the debt to equity ratio for Medi Assist Healthcare Services, MedPlus Health Services and Nephroplus?
Ans. Medi Assist Healthcare Services carries a debt to equity of 0.06, MedPlus Health Services of 0.72, and Nephroplus of 0.07.
Which of the three trades at the highest price to book value?
Ans. Medi Assist Healthcare Services, MedPlus Health Services and Nephroplus trade at price to book ratios of 2.79, 3.98 and 5.83 respectively.
Is one of Medi Assist Healthcare Services, MedPlus Health Services or Nephroplus better than the others?
Ans. This comparison does not declare one stock better than another; each company scores differently across valuation, profitability and dividend metrics, and the right fit depends on an individual investor’s own criteria and research.